| Seroprevalence of severe acute respiratory syndrome coronavirus 2 IgG in Juba, South Sudan, 2020 KE Wiens, PN Mawien, J Rumunu, D Slater, FK Jones, S Moheed, ... Emerging infectious diseases 27 (6), 1598, 2021 | 39 | 2021 |
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study KE Wiens, PN Mawien, J Rumunu, D Slater, FK Jones, S Moheed, ... medRxiv, 2021 | 37 | 2021 |
| Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: A systematic review and meta-analysis KE Wiens, H Xu, K Zou, J Mwaba, J Lessler, EB Malembaka, MN Demby, ... PLoS medicine 20 (9), e1004286, 2023 | 4 | 2023 |
| Towards estimating true cholera burden: a systematic review and meta-analysis of Vibrio cholerae positivity KE Wiens, H Xu, K Zou, J Mwaba, J Lessler, EB Malembaka, MN Demby, ... medRxiv, 2022.10. 05.22280736, 2022 | 3 | 2022 |
| Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study EB Malembaka, PM Bugeme, C Hutchins, H Xu, JD Hulse, MN Demby, ... The Lancet Infectious Diseases, 2024 | 2 | 2024 |
| Towards estimating true cholera burden: a systematic review and meta-analysis ofVibrio choleraepositivity KE Wiens, H Xu, K Zou, J Mwaba, J Lessler, EB Malembaka, MN Demby, ... | 1 | 2022 |
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study (preprint) KE Wiens, PN Mawien, J Rumunu, D Slater, FK Jones, S Moheed, ... | | 2021 |
